We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Oral Arguments Held In Dispute Over Controlled Release Budesonide Tablet

Mealey's (January 11, 2019, 1:18 PM EST) -- WASHINGTON, D.C. — An appeal of a Delaware federal judge’s determination that a patented pharmaceutical tablet with a core composed of a “macroscopically homogenous composition” for controlling the release of budesonide...
To view the full article, register now.